RSR Limited
Records under this name other than the patents RSR Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,110,664 | Binding partners for the thyrotropin receptor and uses thereof Term ended Term ended Apr 5, 2025 · From the USPTO record | Term ended | Term ended Apr 5, 2025 | From the USPTO record |
| US 8,129,132 | Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin Term ended Term ended Oct 20, 2024 · From the USPTO record | Term ended | Term ended Oct 20, 2024 | From the USPTO record |
| US 8,753,637 | Binding partners for the thyrotropin receptor and uses thereof Term ended Ended no later than Nov 28, 2023 · From the USPTO record | Term ended | Ended no later than Nov 28, 2023 | From the USPTO record |
| US 8,900,823 | Binding partners for the thyrotropin receptor and uses thereof Term ended Term ended Nov 28, 2023 · From the USPTO record | Term ended | Term ended Nov 28, 2023 | From the USPTO record |
| US 10,488,410 | Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin Term ended Term ended Aug 12, 2023 · From the USPTO record | Term ended | Term ended Aug 12, 2023 | From the USPTO record |
| US 10,481,156 | Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin Term ended Term ended Aug 8, 2023 · From the USPTO record | Term ended | Term ended Aug 8, 2023 | From the USPTO record |
| US 8,298,769 | Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto Term ended Term ended Jun 24, 2023 · From the USPTO record | Term ended | Term ended Jun 24, 2023 | From the USPTO record |
| US 9,435,797 | Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin Term ended Ended no later than Nov 26, 2022 · From the USPTO record | Term ended | Ended no later than Nov 26, 2022 | From the USPTO record |
| US 8,298,771 | Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto Term ended Ended no later than Aug 21, 2022 · From the USPTO record | Term ended | Ended no later than Aug 21, 2022 | From the USPTO record |
| US 8,309,693 | Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto Term ended Term ended Aug 21, 2022 · From the USPTO record | Term ended | Term ended Aug 21, 2022 | From the USPTO record |